INTRODUCTION
============

Over the past 20 years, the etiology, epidemiology, and outcomes of infective endocarditis (IE) have changed \[[@b1-kjim-2016-106]-[@b3-kjim-2016-106]\]. In particular, the population at risk for IE is no longer young people with known rheumatic valvulopathy, but rather now includes elderly people with degenerative valve disease \[[@b4-kjim-2016-106]\]. In addition, invasive therapeutic interventions such as placement of central intravenous catheters, intracardiac devices, and hemodialysis have increased the risk of nosocomial infections including bacteremia and endocarditis in this population \[[@b5-kjim-2016-106]-[@b8-kjim-2016-106]\]. Nosocomial infective endocarditis (NIE) is a serious complication of nosocomial bacteremia and results in prolonged hospitalization and high mortality rates \[[@b5-kjim-2016-106],[@b7-kjim-2016-106]\]. NIE has various clinical manifestations that depend on the patient's underlying disease, the causal microorganism, and the presence of complications \[[@b9-kjim-2016-106]\]. As a result, appropriate diagnosis and management of patients with NIE, as well as estimation of prognosis, are very important.

To our knowledge, however, few reports have evaluated the clinical characteristics of NIE in Asia. Therefore, the aim of our study was to describe the clinical characteristics of and risk factors for NIE compared with community-acquired infective endocarditis (CIE) and to determine the associated risk factors for short-term clinical outcomes such as in-hospital mortality.

METHODS
=======

Patient population and data collection
--------------------------------------

All consecutive adult patients (≥ 15 years of age) who were diagnosed with IE between January 2000 and July 2014 at Samsung Medical Center (Seoul, Korea), a tertiary university hospital, were screened for inclusion in this study. We retrospectively reviewed medical records from each of these patients including blood culture results and echocardiographic data. The diagnosis of IE was confirmed by modified Duke criteria (2000) and medical records \[[@b10-kjim-2016-106]\]. A total of 560 patients met the modified Duke criteria for definite or possible IE. From their electronic medical records, additional information was collected including demographic characteristics, underlying medical disease, recent history of predisposing manipulations, microbiological and echocardiographic features, short-term outcomes, surgical treatment, and complications. This study was approved by Institutional Review Board of Samsung Medical Center, and the requirement of informed consent was waived.

Echocardiographic findings
--------------------------

All patients analyzed in this study underwent transthoracic echocardiography (TTE). Transesophageal echocardiography (TEE) was also performed in most of the patients. We investigated the vegetation site, vegetation size, presence of valve disease, and complications such as abscess or tissue perforation. The vegetation size was measured in various planes according to maximal length and width. The severity of valvular regurgitation was estimated by Doppler examination with semiquantitative standard criteria, and the presence of a perivalvular abscess was identified as an abnormal localized echogenic mass without internal blood flow.

Microbiological etiology
------------------------

The microbiological information was obtained from blood cultures, intraoperative heart tissue sample cultures and serological studies. Blood samples for culture were drawn under sterile conditions according to the hospital's standard guideline. The microorganism isolated from blood cultures was considered to be the cause of IE in all patients with clinical manifestations of IE. Culture-negative IE was diagnosed when the patients with clinical manifestations of IE showed negative blood and/or intraoperative cultures.

Surgery
-------

All information was collected by the attending physicians who established the indication for cardiac surgery according to guideline \[[@b3-kjim-2016-106]\].

Definitions
-----------

IE was classified as NIE if the diagnosis was made \> 72 hours after hospital admission and there was no evidence of infection at the time of admission. Additionally, NIE was diagnosed if IE occurred within 60 days after hospital discharge when a high risk procedure for bacteremia was performed or when any predisposing factor for IE was present during hospitalization \[[@b11-kjim-2016-106]-[@b15-kjim-2016-106]\]. The underlying cardiac condition was classified according to the presence of a native valve, congenital heart disease, or a prosthetic valve.

Large vegetations were defined as those equal to or larger than 2 cm in maximal length \[[@b11-kjim-2016-106]\]. Systemic and pulmonary embolic events as well as mycotic aneurysmal events confirmed on imaging studies such as computed tomography, magnetic resonance imaging, or echocardiography were recorded. The short-term outcome studied was in-hospital death, which was defined as death from any cause during hospitalization \[[@b11-kjim-2016-106]\].

Statistical analysis
--------------------

Quantitative variables are reported as mean ± standard deviation (SD). On univariate analysis, Student *t* tests were used for continuous variables and chi-square tests were used for categorical variables in comparing the distribution of NIE with CIE. *p* values less than 0.05 were considered to be statistically significant. Clinical risk factors associated with NIE were determined on multiple analysis. Clinical variables affecting in-hospital death that were determined on univariate analysis (*p* \< 0.05) were analyzed by logistic regression in patients with NIE. All analyses were performed using SPSS version 20.0 (IBM Co., Armonk, NY, USA).

RESULTS
=======

A total of 560 cases of IE were diagnosed between 2000 and 2014. Among them, 121 cases were diagnosed as NIE and 439 as CIE. In assessing cases in 5-year periods over 15 years, we observed an increasing trend in the absolute number of patients with NIE; the 1st, 2nd, and 3rd period contained 27, 37, and 57 cases, respectively ([Fig. 1](#f1-kjim-2016-106){ref-type="fig"}). Likewise, there was a pattern of increase in the number of patients with CIE; the 1st, 2nd, and 3rd period contained 101, 120, and 218 cases, respectively ([Fig. 1](#f1-kjim-2016-106){ref-type="fig"}).

Patients and clinical characteristics
-------------------------------------

The clinical characteristics of NIE compared with CIE are summarized in [Table 1](#t1-kjim-2016-106){ref-type="table"}. NIE patients were older than the CIE patients (mean ± SD, 59.76 ± 14.87 years vs. 51.30 ± 18.01 years, *p* \< 0.001). With respect to underlying medical diseases, the incidence of liver cirrhosis (LC) (*p* = 0.002), diabetes mellitus (DM) (*p* = 0.045), malignancy (solid and hematologic) (*p* \< 0.001), chemotherapy for malignancy (*p* \< 0.001), and chronic kidney disease (CKD) (*p* \< 0.001) were higher in NIE patients. IE occurring on native valves was more common in the NIE group (84.3% vs. 74.9%, *p* = 0.038), while IE occurring in patients with congenital heart disease was more frequent in the CIE group (4.1% vs. 21.6%, *p* \< 0.001). The presence of a central intravenous catheter (33.1% vs. 2.1%, *p* \< 0.001) and hemodialysis (15.7% vs. 3.4%, *p* \< 0.001) were more common in the NIE group. Predisposing procedures related with the occurrence of IE were present in 15 of 121 NIE cases (12.4%), and in 52 of 439 CIE cases (11.8%) ([Table 1](#t1-kjim-2016-106){ref-type="table"}). A history of acupuncture or articular injection (*p* = 0.031) and dental manipulation (*p* = 0.002) were more common in the CIE group ([Table 1](#t1-kjim-2016-106){ref-type="table"}), whereas more specific procedures were more common in NIE patients; four patients in the NIE group had a history of endoscopic esophageal variceal ligation, compared with one patient in the CIE group (*p* = 0.009). Genitourinary tract manipulation was performed in four patients with NIE and two patients with CIE (*p* = 0.022).

On multiple analysis, age, LC, chemotherapy, presence of a central intravenous catheter, hemodialysis, and genitourinary tract manipulation as predisposing procedure were independently associated with NIE as clinical risk factors ([Table 2](#t2-kjim-2016-106){ref-type="table"}).

Echocardiographic findings
--------------------------

Echocardiographic findings for both groups are also shown in [Table 1](#t1-kjim-2016-106){ref-type="table"}. The mitral valve was the most common vegetation site in both groups, and its incidence was higher in the CIE group (*p* = 0.023). Vegetation involvement of the right atrium was more common in the NIE group (*p* = 0.006). Both TTE and TEE were performed in 417 patients. The vegetations were found in the 387 patients. Among them, 103 patients were found to have vegetations in TEE only. Among 103 patients, 75 patients (72.8%) did not have the significant valvular regurgitant lesion, 88 patients (85.4%) had single site involvement of vegetation, and 83 patients (80.6%) had small size of vegetation such as \< 1 cm. In addition, 38 patients (36.9%) were belonged to prosthetic valve or repaired valve endocarditis.

Causative microorganisms of NIE
-------------------------------

Blood culture data for the NIE and CIE groups are also presented in [Table 1](#t1-kjim-2016-106){ref-type="table"}. Overall, blood culture positive IE was more frequently observed in the NIE group. Viridans group streptococci were the most frequent microorganisms involved in CIE (n = 128 cases, 29.2%), followed by Staphylococcus aureus (n = 85 cases, 19.4%). However, S. aureus was the most frequent pathogen in the NIE group (n = 47 cases, 38.3%), with methicillin-resistant *Staphylococcus aureus* (MRSA) as the major pathogen. Fungus was also a common cause of NIE.

Clinical outcomes
-----------------

Clinical outcomes such as in-hospital death, frequency of cardiac surgery, and occurrence of an embolic event or mycotic aneurysm are shown in [Table 1](#t1-kjim-2016-106){ref-type="table"}. The in-hospital death rate of the NIE group was much higher than that of the CIE group (27.3% vs. 5.9%, *p* \< 0.001). Cardiac surgery was conducted for the treatment of IE significantly less often in cases of NIE than in cases of CIE (38.0% vs. 67.9%, *p* \< 0.001). Furthermore, the number of cases that had surgical indication for management, but had not undergone surgery, was higher in the NIE group than in the CIE group (24.0% vs. 9.3%, *p* \< 0.001). A total of 157 cases (35.8%) in the CIE group and 48 cases (39.7%) in the NIE group experienced embolic events during their hospitalization (*p* = 0.460). The duration of hospitalization was longer in NIE group (47.33 ± 37.59 days vs. 35.80 ± 21.70 days, *p* \< 0.001).

The association between clinical characteristics and in-hospital death in patients with NIE is depicted in [Tables 3](#t3-kjim-2016-106){ref-type="table"} and [4](#t4-kjim-2016-106){ref-type="table"}. On univariate analysis ([Table 3](#t3-kjim-2016-106){ref-type="table"}), the factors associated with in-hospital death in patients with NIE were age, gender, cancer chemotherapy, surgical indication but not performed, and fungal pathogens. However, on multiple logistic regression ([Table 4](#t4-kjim-2016-106){ref-type="table"}), only older age (adjusted odds ratio \[OR\], 1.04; 95% confidence interval \[CI\], 1.01 to 1.07; *p* = 0.037) and chemotherapy treatment for malignancy (adjusted OR, 3.89; 95% CI, 1.18 to 12.87; *p* = 0.026) remained as independent risk factors associated with in-hospital mortality.

In patients with CIE, the association between clinical characteristics and in-hospital death is depicted in [Tables 3](#t3-kjim-2016-106){ref-type="table"} and [5](#t5-kjim-2016-106){ref-type="table"}, as the same method of analysis was used for NIE. On univariate analysis ([Table 3](#t3-kjim-2016-106){ref-type="table"}), the factors associated with in-hospital death in patients with CIE were age, indication of cardiac surgery but not performed, and causative pathogens like as viridans group streptococci and MRSA. However, on multiple logistic regression ([Table 5](#t5-kjim-2016-106){ref-type="table"}), it was concluded that older age (adjusted OR, 1.04; 95% CI, 1.01 to 1.07; *p* = 0.012), indication of cardiac surgery but not done (adjusted OR, 29.83; 95% CI, 10.19 to 87.31; *p* \< 0.001), and MRSA (adjusted OR, 9.58; 95% CI, 2.27 to 40.45; *p* = 0.002) as virulent pathogen were clinically significant variables in the analysis.

DISCUSSION
==========

In recent years, there have been major changes in the epidemiology of IE, including increased age of patients, presence of predisposing factors, and higher rates of NIE, which is related to more frequent use of intravascular devices and procedures \[[@b1-kjim-2016-106],[@b5-kjim-2016-106],[@b16-kjim-2016-106]\]. NIE reported in other studies accounts for 10% to 30% of all IE cases, similar to what was seen in our study (21.6% of all patients) \[[@b2-kjim-2016-106],[@b9-kjim-2016-106],[@b11-kjim-2016-106],[@b17-kjim-2016-106]-[@b19-kjim-2016-106]\]. This finding could be explained by increases in the number of nosocomial blood stream infections, the number of patients admitted to intensive care units, the number of invasive vascular procedures performed, and in the higher incidence of degenerative valve disease in the aged population \[[@b11-kjim-2016-106],[@b15-kjim-2016-106],[@b18-kjim-2016-106]-[@b24-kjim-2016-106]\]. In addition, other reasons for the growing numbers of reported NIE cases include the greater diagnostic yield of TEE \[[@b25-kjim-2016-106]\] and extension of incubation periods to culture a greater range of causal organisms \[[@b5-kjim-2016-106]\].

In this study, we found that the ratio of NIE cases remained stationary over three 5-year periods. However, the absolute number of patients with NIE has increased continuously. The growing problem of NIE as a large part of all IE cases calls for more careful monitoring of complications after procedures and more appropriate management of immunosuppressed patients, especially in light of recent increased frequencies of invasive procedures and or aggressive medical management.

The clinical features of NIE and its prognosis were evaluated in the current study. There was significant association of NIE with central intravenous catheter-related infections, hemodialysis, and underlying disease such as LC, DM, malignancy, chemotherapy for malignancy, and CKD. Among these factors, increased age, LC, malignancy, and presence of a central intravenous catheter were independently associated with NIE on multivariate analysis, suggesting an increased frequency of NIE in immunocompromised patients as above. Also, these underlying diseases could predispose the patient to the development of concomitant infections due to associated immunosuppression, more invasive procedures, and more frequent hospitalizations \[[@b9-kjim-2016-106],[@b19-kjim-2016-106]\].

The procedural source of infection determined the causative organism in cases of NIE. When the source was an intravascular device or procedure, staphylococci were the most frequent etiologic agent \[[@b12-kjim-2016-106],[@b26-kjim-2016-106],[@b27-kjim-2016-106]\]. In NIE patients of our study, the microbiological etiology was analyzed by predisposing procedures. With endoscopic procedures, two cases of viridans group streptococci, one case of methicillin-sensitive *Staphylococcus aureus*, and one case of enterococcus were identified. Two cases of MRSA were found, one in transcatheter arterial chemoembolization, and other in liver biopsy. Two cases as MRSA in the procedure of orthopedic prosthesis, and one case of MRSA with intracardiac device was recognized. It showed staphylococcal infection was dominant in NIE. In the procedure of genitourinary tract manipulation, however, three cases of enterococcus among four patients were found. Furthermore, in our study, the greater frequency of a central intravenous catheter (33.1% vs. 2.1%, *p* \< 0.001) and hemodialysis (15.7% vs. 3.4%, *p* \< 0.001) in the NIE group could explain why the most common etiologic agent causing NIE was MRSA, which was found in 23.1% of patients of the NIE group.

Despite advances in medical and surgical treatment, mortality rates for IE have remained unchanged over the last 20 years, which can be explained by the remarkable epidemiologic shift that now includes elderly patients with multiple comorbidities \[[@b9-kjim-2016-106]\]. Our study showed that patients with NIE were frailer than those with CIE, as indicated by their underlying health issues. In-hospital mortality was higher in the NIE group than in the CIE group. Older age was an independent clinical factor in both groups that determined in-hospital mortality. Among other associated risk factors for in-hospital mortality, chemotherapy treatment was the other independent clinical risk factor for the NIE group. In the CIE group, MRSA as the causative pathogen was an additional clinical risk factor that determined in-hospital mortality. These results suggest that the mortality of NIE is influenced mainly by patients' general health conditions, whereas the virulence of the disease-causing pathogen is an additional important mortality factor of CIE.

The percentage of patients who were indicated for but did not undergo cardiac surgery was higher in the NIE group than the CIE group ([Table 1](#t1-kjim-2016-106){ref-type="table"}). In another study \[[@b19-kjim-2016-106]\], cardiac surgery that was indicated but not performed was an associated clinical risk factor in patients with NIE. However, it was not confirmed as an independent risk factor in the current study. This could be because other mortality related risk factors, such as older age and serious underlying disease, were the main causes for patients not to undergo cardiac surgery. This could also be explained by the small number of this subset of patients in the NIE group.

Our study has several limitations. It is subject to referral bias since it was conducted at a large tertiary care medical center and is retrospective in design. Although increase in the number of NIE patients was shown, there was no proportional increase of NIE patients. The authors do not have a correct answer to explain the phenomenon. There may be a proportional increase of invasive procedures in response to increase of high risk patients for IE. However, it needs a multicenter prospective study to find out the answer.

Some of the underlying diseases may be associated with the in-hospital mortality in patients with NIE, but we could not confirm any independent associations of these underlying diseases with mortality. This might be because of the small number of patients with each underlying disease. However, the total 560 cases enrolled in our study between 2000 and 2014 were larger than those of other studies \[[@b18-kjim-2016-106],[@b21-kjim-2016-106]\].

In conclusion, the incidence of NIE is not low, and the general in-hospital mortality of NIE is quite high. Therefore, it is important that clinicians, particularly those in tertiary care hospital centers where a great number of ambulatory procedures (e.g., hemodialysis and chemotherapy for malignancy) are performed, be aware of the risk of endocarditis in patients who have undergone invasive procedures that could potentially cause bacteremia. Prompt diagnosis by echocardiography and active management would be warranted if NIE is suspected.

KEY MESSAGE
===========

1\. It is important that clinicians, particularly those in tertiary care hospital centers where a great number of ambulatory procedures are performed, be aware of the risk of endocarditis in patients who have undergone invasive procedures that could potentially cause bacteremia.

2\. Prompt diagnosis by echocardiography and active management would be warranted if nosocomial infective endocarditis is suspected.
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###### 

Baseline clinical characteristics and clinical outcomes of NIE compared with CIE

  Characteristic                                     CIE (n = 439)   NIE (n = 121)   *p* value
  -------------------------------------------------- --------------- --------------- -----------
  Age, yr                                            51.30 ± 18.01   59.76 ± 14.87   \< 0.001
  Male sex                                           281 (64.0)      64 (52.9)       0.027
  Definite infective endocarditis                    312 (71.1)      94 (77.7)       0.170
  Underlying medical disease                                                         
   Liver cirrhosis                                   14 (3.2)        13 (10.7)       0.002
   Alcoholism                                        8 (1.8)         4 (3.3)         0.300
   Diabetes mellitus                                 32 (7.3)        16 (13.2)       0.045
   Chemotherapy                                      16 (3.6)        35 (28.9)       \< 0.001
   Malignancy                                        32 (7.3)        52 (43.0)       \< 0.001
   Chronic kidney disease                            22 (5.0)        20 (16.5)       \< 0.001
   Hemodialysis                                      15 (3.4)        19 (15.7)       \< 0.001
   Solid organ transplantation                       1 (0.2)         1 (0.8)         0.390
   Coronary artery disease                           13 (3.0)        7 (5.8)         0.160
   Rheumatologic disease                             4 (0.9)         2 (1.7)         0.620
   Cerebrovascular accident                          13 (3.0)        2 (1.7)         0.750
   Cardiomyopathy                                    5 (1.1)         1 (0.8)         1.000
   Recurrent infection (biliary, urinary)            4 (0.9)         1 (0.8)         1.000
   Other site abscess                                11 (2.5)        4 (3.3)         0.540
   COPD & ILD                                        5 (1.1)         2 (1.7)         0.650
   Tuberculosis                                      15 (3.4)        3 (2.5)         0.780
   Vascular disease (vasculitis)                     3 (0.7)         1 (0.8)         1.000
  Underlying cardiac condition                                                       
   Congenital heart disease                          95 (21.6)       5 (4.1)         \< 0.001
   Prosthetic valve                                  84 (19.1)       17 (14.0)       0.230
   Native valve                                      329 (74.9)      102 (84.3)      0.038
  Central intravenous catheter                       9 (2.1)         40 (33.1)       \< 0.001
  Past history of infective endocarditis             31 (7.1)        3 (3.3)         0.200
  Predisposing manipulation                                                          
   Acupuncture or articular injection                17 (3.9)        0               0.031
   Dental manipulation                               26 (5.9)        0               0.002
   Endoscopy with procedure                          1 (0.2)         4 (3.3)         0.009
   TACE or liver biopsy                              2 (0.5)         2 (1.7)         0.210
   Genitourinary tract manipulation                  2 (0.5)         4 (3.3)         0.022
   Orthopedic prosthesis                             1 (0.2)         2 (1.7)         0.120
   Perivertebral area procedure                      2 (0.5)         2 (1.7)         0.210
   Intracardiac device (PPM, ICD)                    1 (0.2)         1 (0.8)         0.390
  Echocardiographic finding                                                          
   Transesophageal echocardiogram                    342 (77.9)      75 (62.0)       \< 0.001
   Vegetation                                                                        
    Mitral valve                                     258 (58.8)      57 (47.1)       0.023
    Aortic valve                                     163 (37.1)      48 (39.7)       0.670
    Tricuspid valve                                  30 (6.8)        12 (9.9)        0.250
    Pulmonary valve                                  17 (3.9)        1 (0.8)         0.140
    Right ventricle                                  15 (3.4)        1 (0.8)         0.210
    Right atrium                                     7 (1.6)         8 (6.6)         0.006
    Other site                                       22 (5.0)        6 (5.0)         1.000
   Significant valvular regurgitation                214 (48.7)      40 (33.1)       0.003
   Large vegetation (\> 2 cm)                        34 (7.7)        10 (8.3)        0.750
   Perivalvular abscess                              60 (13.7)       15 (12.4)       0.770
   Perforation                                       36 (8.2)        7 (5.8)         0.450
  Causative organism                                                                 
   Viridans group streptococci                       128 (29.2)      8 (6.6)         \< 0.001
   *Staphylococcus aureus*                                                           
    Methicillin-sensitive                            63 (14.4)       19 (15.7)       0.770
    Methicillin-resistant                            22 (5.0)        28 (23.1)       \< 0.001
   *Enterococcus*                                    31 (7.1)        15 (12.4)       0.060
   Coagulase-negative *Staphylococcus*               19 (4.3)        11 (9.1)        0.060
   HACEK                                             7 (1.6)         0               0.360
   Fungus                                            2 (0.5)         6 (5.0)         0.002
   Other bacteria                                    55 (12.5)       20 (16.5)       0.290
   Culture negative infective endocarditis           129 (29.4)      16 (13.2)       \< 0.001
  Clinical outcomes                                                                  
   In-hospital death                                 26 (5.9)        33 (27.3)       \< 0.001
   Cardiac surgery                                   298 (67.9)      46 (38.0)       \< 0.001
   On indication of cardiac surgery (but not done)   41 (9.3)        29 (24.0)       \< 0.001
   Embolic event                                     157 (35.8)      48 (39.7)       0.460
    Brain                                            118 (26.9)      34 (28.1)       0.820
    Kidney                                           14 (3.2)        5 (4.1)         0.580
    Spleen                                           21 (4.8)        6 (5.0)         1.000
    Lung                                             18 (4.1)        7 (5.8)         0.460
    Extremities                                      14 (3.2)        6 (5.0)         0.410
    Liver                                            2 (0.5)         1 (0.8)         0.520
    Eye (retina)                                     6 (1.4)         2 (1.7)         0.690
   Mycotic aneurysm                                  20 (4.5)        5 (4.1)         1.000
  Duration of hospitalization, day                   35.80 ± 21.70   47.33 ± 37.59   \< 0.001

Values are presented as mean ± SD or number (%).

NIE, nosocomial infective endocarditis; CIE, community-acquired infective endocarditis; COPD, chronic obstructive pulmonary disease; ILD, interstitial lung disease; TACE, transcatheter arterial chemoembolization; PPM, permanent pacemaker; ICD, implantable cardioverter defibrillator; HACEK, *Haemophilus parainfluenzae, Haemophilus aphrophilus, Aggregatibacter actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae*.

###### 

Univariate and multiple analysis of clinical factors associated with nosocomial infective endocarditis

  Variable                           Crude                  Adjusted                         
  ---------------------------------- ---------------------- ---------- --------------------- ----------
  Age                                1.03 (1.02--1.04)      \< 0.001   1.02 (1.001--1.04)    0.006
  Male sex                           1.58 (1.06--2.38)      0.027      1.43 (0.86--2.38)     0.170
  Liver cirrhosis                    3.65 (1.67--8.00)      0.001      4.57 (1.86--11.21)    0.001
  Diabetes mellitus                  1.94 (1.03--3.67)      0.042      1.47 (0.67--3.25)     0.340
  Chemotherapy                       10.76 (5.70--20.31)    \< 0.001   5.03 (2.29--11.06)    \< 0.001
  Central intravenous catheter       23.59 (11.0 --50.50)   \< 0.001   10.18 (4.21--24.62)   \< 0.001
  Hemodialysis                       5.27 (2.59--10.72)     \< 0.001   2.58 (1.02--6.53)     0.046
  Endoscopy with procedure           14.97 (1.66--135.25)   0.016      10.53 (0.98--13.54)   0.052
  Genitourinary tract manipulation   7.47 (1.35--41.59)     0.021      11.22 (1.84--68.36)   0.009

OR, odds ratio; CI, confidence interval.

Estimated by multiple linear regression analysis of the variables indicated in the table.

###### 

Clinical characteristics in dead patients compared with survived patient for the group of NIE and CIE by univariate analysis

  Characteristic                                    NIE             CIE                                                     
  ------------------------------------------------- --------------- --------------- ------- --------------- --------------- ----------
  Age, yr                                           58.08 ± 15.72   64.24 ± 11.36   0.020   50.34 ± 17.62   66.54 ± 17.65   \< 0.001
  Male sex                                          52 (59.1)       12 (36.4)       0.040   264 (63.9)      17 (65.4)       1.000
  Underlying medical disease                                                                                                
   Liver cirrhosis                                  9 (10.2)        4 (12.1)        0.750   12 (2.9)        2 (7.7)         0.200
   Alcoholism                                       4 (4.5)         0               0.570   8 (1.9)         0               1.000
   Diabetes mellitus                                14 (15.9)       2 (6.1)         0.230   31 (7.5)        1 (3.8)         0.710
   Chemotherapy                                     20 (22.7)       15 (45.5)       0.023   15 (3.6)        1 (3.8)         1.000
   Malignancy                                       32 (36.4)       20 (60.6)       0.023   28 (6.8)        4 (15.4)        0.110
   Chronic kidney disease                           18 (20.5)       2 (6.1)         0.100   19 (4.6)        3 (11.5)        0.130
   Hemodialysis                                     17 (19.3)       2 (6.1)         0.100   13 (3.1)        2 (7.7)         0.220
   Solid organ transplantation                      0               1 (3.0)         0.270   1 (0.2)         0               1.000
   Coronary artery disease                          6 (6.8)         1 (3.0)         0.670   12 (2.9)        1 (3.8)         0.550
   Rheumatologic disease                            1 (1.1)         1 (3.0)         1.000   4 (1.0)         0               1.000
   Cerebrovascular accident                         1 (1.1)         1 (3.0)         1.000   13 (3.1)        0               1.000
   Cardiomyopathy                                   1 (1.1)         0               1.000   4 (1.0)         1 (3.8)         0.260
   Recurrent infection (biliary, urinary)           1 (1.1)         0               1.000   3 (0.7)         1 (3.8)         0.220
   Other site abscess                               4 (4.5)         0               0.570   9 (2.2)         2 (7.7)         0.130
   COPD & ILD                                       0               2 (6.1)         0.070   5 (1.2)         0               1.000
   Tuberculosis                                     3 (3.4)         0               0.560   15 (3.6)        0               1.000
   Vascular disease (vasculitis)                    1 (1.1)         0               1.000   3 (0.7)         0               1.000
  Underlying cardiac condition                                                                                              
   Congenital heart disease                         4 (4.5)         1 (3.0)         1.000   95 (23.0)       0               0.002
   Prosthetic valve                                 12 (13.6)       5 (15.2)        0.780   76 (18.4)       8 (30.8)        0.130
   Native valve                                     15 (17.0)       4 (12.1)        0.590   308 (74.6)      21 (80.8)       0.640
  On indication of cardiac surgery (but not done)   16 (18.2)       13 (39.4)       0.030   24 (5.8)        17 (65.4)       \< 0.001
  Central intravenous catheter                      28 (31.8)       12 (36.4)       0.670   8 (1.9)         1 (3.8)         0.430
  Past history of infective endocarditis            1 (1.1)         3 (9.1)         0.060   29 (7.0)        2 (7.7)         0.700
  Predisposing manipulation                                                                                                 
   Acupuncture or articular injection               0               0               NA      17 (4.1)        0               0.610
   Dental manipulation                              0               0               NA      24 (5.8)        2 (7.7)         0.660
   Endoscopy with procedure                         4 (4.5)         0               0.570   1 (0.2)         0               1.000
   TACE or liver biopsy                             1 (1.1)         1 (3.0)         0.470   2 (0.5)         0               1.000
   Genitourinary manipulation                       3 (3.4)         1 (3.0)         1.000   2 (0.5)         0               1.000
   Orthopedic prosthesis                            2 (2.3)         0               1.000   1 (0.2)         0               1.000
   Perivertebral area procedure                     2 (2.3)         0               1.000   2 (0.5)         0               1.000
   Intracardiac device (PPM, ICD)                   1 (1.1)         0               1.000   1 (0.2)         0               1.000
  Causative organism                                                                                                        
   Viridans group streptococci                      5 (5.7)         3 (9.1)         0.680   127 (30.8)      1 (3.8)         0.002
   *Staphylococcus aureus*                                                                                                  
    Methicillin-sensitive                           19 (21.6)       0               0.002   59 (14.3)       4 (15.4)        0.780
    Methicillin-resistant                           17 (19.4)       11 (33.3)       0.150   17 (4.1)        5 (19.2)        0.006
   Enterococcus                                     8 (9.1)         7 (21.2)        0.120   28 (6.8)        3 (11.5)        0.420
   Coagulase-negative *Staphylococcus*              10 (11.4)       1 (3.0)         0.290   18 (4.4)        1 (3.8)         1.000
   HACEK                                            0               0               NA      7 (1.7)         0               1.000
   Fungus                                           2 (2.3)         4 (12.1)        0.046   1 (0.2)         1 (3.8)         0.120
   Other bacteria                                   16 (18.2)       4 (12.1)        0.590   52 (12.6)       3 (11.5)        1.000
   Culture negative                                 11 (12.8)       4 (12.1)        0.410   121 (29.3)      8 (30.8)        0.830

Values are presented as mean ± SD or number (%).

NIE, nosocomial infective endocarditis; CIE, community-acquired infective endocarditis; COPD, chronic obstructive pulmonary disease; ILD, interstitial lung disease; NA, not assessed; TACE, transcatheter arterial chemoembolization; PPM, permanent pacemaker; ICD, implantable cardioverter defibrillator; HACEK, *Haemophilus parainfluenzae, Haemophilus aphrophilus, Aggregatibacter actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae*.

###### 

Association between clinical characteristics and in-hospital death in patients with nosocomial infective endocarditis by multiple analysis

  Variable                                          Crude                Adjusted                        
  ------------------------------------------------- -------------------- ---------- -------------------- -------
  Age                                               1.03 (1.01--1.06)    0.045      1.04 (1.01--1.07)    0.037
  Male sex                                          0.40 (0.17--0.90)    0.028      0.42 (0.17--1.08)    0.070
  Liver cirrhosis                                   1.21 (0.35--4.24)    0.770      2.80 (0.64--12.34)   0.170
  Chemotherapy                                      2.83 (1.21--6.61)    0.016      3.89 (1.18--12.87)   0.026
  Hemodialysis                                      0.27 (0.06--1.24)    0.090      0.36 (0.07--1.91)    0.230
  Central intravenous catheter                      1.22 (0.53--2.83)    0.640      0.82 (0.26--2.63)    0.740
  On indication of cardiac surgery (but not done)   2.93 (1.21--7.08)    0.017      2.18 (0.81--5.88)    0.120
  Fungus                                            5.93 (1.03--34.09)   0.046      4.43 (0.61--31.94)   0.140

OR, odds ratio; CI, confidence interval.

Estimated by multiple linear regression analysis of the variables indicated in the table.

###### 

Association between clinical characteristics and in-hospital death in patients with community-acquired infective endocarditis by multiple analysis

  Variable                                          Crude                  Adjusted                          
  ------------------------------------------------- ---------------------- ---------- ---------------------- ----------
  Age                                               1.06 (1.03--1.09)      \< 0.001   1.04 (1.01--1.07)      0.012
  Male sex                                          1.07 (0.46--2.45)      0.880      1.09 (0.38--3.16)      0.870
  Liver cirrhosis                                   2.79 (0.59--13.15)     0.200      1.13 (0.17--7.30)      0.900
  On indication of cardiac surgery (but not done)   30.62 (12.36--75.84)   \< 0.001   29.83 (10.19--87.31)   \< 0.001
  Viridans group streptococci                       0.09 (0.01--0.67)      0.019      0.14 (0.01--1.16)      0.070
  MRSA                                              5.55 (1.87--16.49)     0.002      9.58 (2.27--40.45)     0.002

OR, odds ratio; CI, confidence interval; MRSA, methicillin-resistant *Staphylococcus aureus*.

Estimated by multiple linear regression analysis of the variables indicated in the table.
